The mercurial and Twitter-obsessed Tesla ($TSLA) CEO changed his handle overnight to "Elon Tusk" with an elephant emoji, and tweeted that there would be "some Tesla news" coming at 2 p.m. on Thursday.
A master of capturing media attention, Musk could be teasing a gimmicky Tesla feature, à la "Dog Mode," that would deflect some of the scrutiny he is once again under for tangling with the SEC over its regulatory practices. Or he could make a more serious announcement related to Model 3 production targets, or even how the company plans to pay off a $920 million convertible bond due on the first of the month.
The point is: no one knows ー and that's the problem. Earlier this week the SEC complained that Musk should be held in contempt for continuing to tweet market-moving investor information without prior sign-off from Tesla lawyers, which was part of Musk's settlement agreement with the agency.
That became infinitely more difficult when the company's general counsel quit last week after just two months.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Aileen Del Cid, head of marketing at Samsung TV Plus, sat down with Cheddar News reporter Michelle Castillo to discuss the platform's plans to stand out from the streaming competition with a new channel featuring Conan O'Brien.
Stocks rose in midday trading on Wall Street Friday, led by more gains in technology stocks as another chipmaker reported strong demand related to artificial intelligence.
